AVH 6.48% $2.63 avita medical inc.

Webinar, page-7

  1. 639 Posts.
    lightbulb Created with Sketch. 342
    you were to busy listening to the umms and ignoring the detail. What’s not to like in this medical breakthrough technology, first and foremost it works. As for the detail plenty.
    At the very start he presents the applications, nine shown, then explains there are many more not shown.
    100 mil in the bank and no debt.
    all up 22 billion market when they are finished with FDA.
    Japan on board and proceeding to market.
    patents now extended out further 10 to 20 years.
    Barda funding into the wounds trials.
    No other treatment on the planet yet for Vitilago and it has a 5.6 billion market.
    Only 12 months left to FDA approval of vitilago and wounds then commercial.
    Didnt listen to it all, missed the feedbacks but enough to determine a share price of $2 is a total giveaway.
    umm all of the above spells income.

 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.